UVV — what changed in the latest 10-Q
A section-by-section comparison of UVV's newest periodic SEC filing (10-K/10-Q) against the prior same-form filing: paragraphs added and removed per section, with verbatim excerpts. Purely a deterministic text diff — no similarity scores, no directional read, not investment advice.
Comparing 10-Q · 2026-11-04 vs the prior 10-Q · 2026-08-05
| Section | Outcome | Added | Removed | Minor | Unchanged |
|---|---|---|---|---|---|
| MD&A | Text added/removed | +29 | −22 | ~18 | 6 |
| Market risk (Item 3) | Text added/removed | 0 | 0 | ~1 | 0 |
| Controls & procedures | Text added/removed | 0 | 0 | ~2 | 0 |
| Legal proceedings | No paragraph-level changes | 0 | 0 | 0 | 1 |
| Risk factors | No material changes reported (points to the 10-K) | — | — | — | — |
| Other information | Text added/removed | +2 | −1 | 0 | 0 |
Counts are paragraphs; added/removed means text added or removed vs the prior filing — no direction or judgement implied.
Representative excerpts
Up to 5 excerpts of about 300 characters per section, quoted verbatim from the two SEC filings.
MD&A
Text added vs the prior filing · source: 10-Q · 2026-11-04
We believe our market leadership and century of experience have positioned us well to navigate the current tobacco market dynamics. Our first-half results reflect the slower timing of tobacco shipments due to this delayed oversupply cycle, and we enter the second half of fiscal year 2027 encouraged …
At Universal Ingredients, we are taking decisive actions to strengthen performance and position the business for long-term growth. We are transforming our platform into a more integrated and aligned organization, a process we expect to continue through our fiscal year 2028. This will sharpen our com…
Three Months Ended September 30,ChangeSix Months Ended September 30,Change
Selling, general, and administrative expenses were down by 6%, or $4.6 million, primarily due to an insurance recovery of $4 million, favorable foreign currency comparisons of $2.2 million, and lower legal and professional fees of $1.0 million, partially offset by lower recoveries on advances to sup…
Revenue decreased by 19%, or $125.1 million, for the quarter ended September 30, 2026, compared to the quarter ended September 30, 2025, primarily on a 23% decrease in tobacco sales volumes due to a delayed tobacco market cycle this fiscal year, partially offset by a 3% increase in tobacco sales pri…
Text removed vs the prior filing · source: 10-Q · 2026-08-05
We are starting fiscal year 2027 with confidence in the long-term strategic direction of our company. We are focused on creating sustainable value through disciplined execution across our businesses. In tobacco, we believe that our long-standing market expertise and measured approach position us wel…
Our results for the quarter ended June 30, 2026, reflected the expected timing and market dynamics in our tobacco business, in comparison to our first quarter fiscal year 2026 results, which we believe were exceptional. Purchasing activity was slower as we and our customers evaluated green tobacco p…
Net income (loss) attributable to Universal Corporation$(5.0)$8.5 (159)%
Adjusted net income (loss) attributable to Universal Corporation (non-GAAP)*$(5.0)$9.6 (152)%
Tobacco operations sales and other operating revenues$437.1 $504.7 (13)%
Other information
Text added vs the prior filing · source: 10-Q · 2026-11-04
On August 13, 2026, Airton L. Hentschke adopted a Rule 10b5-1 trading arrangement (as such term is defined in Item 408 of Regulation S-K of the Securities Act) providing for the sale from time to time of an aggregate of up to 19,970 shares of common stock. The duration of the trading arrangement is …
Except as provided above, during the three months ended September 30, 2026, none of our directors or officers (as defined in Rule 16a-1(f) of the Exchange Act) adopted or terminated a Rule 10b5-1 trading arrangement (as such terms are defined in Item 408 of Regulation S-K of the Securities Act).
Text removed vs the prior filing · source: 10-Q · 2026-08-05
During the three months ended June 30, 2026, none of our directors or officers (as defined in Rule 16a-1(f) of the Securities Exchange Act of 1934, as amended) adopted or terminated a Rule 10b5-1 trading arrangement (as such terms are defined in Item 408 of Regulation S-K of the Securities Act of 19…
How to read Risk Factors (Item 1A) in a 10-Q
A 10-Q risk-factor section usually takes one of three forms; this page classifies it as one of:
- Pointer — the filer states there have been no material changes and points back to the annual 10-K risk factors; there is no own risk text to compare this quarter.
- Partial update — the filer carves out specific updated risks ("except as set forth below"); the excerpts show exactly what is new this quarter.
- Restated in full — the quarter carries the complete risk-factor text. When the prior quarter was only a pointer there is no prior full text to diff against, so the page flags the section as restated instead.
This describes the filing structure only — it is never a judgement on whether risk went up or down.
Source: text-level diff of the two SEC EDGAR filings · deterministic (no AI-generated content) · for reference only · not investment advice